SANDOZ GLICLAZIDE MR

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: d1249cc1203d9f0e
Drug Approval Canada Name: SANDOZ GLICLAZIDE MR
Product Name: SANDOZ GLICLAZIDE MR
Status: Marketed
Status Date: 2017-06-02
Original Market Date: 2017-06-02
Din: 02461331
Drug Class: Human
Dosage Form: Tablet (Extended-Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:20.20
Atc Original: A10BB09 GLICLAZIDE
Atc Name: a 10 bb 09
Aig Number: 0119934003
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

GLICLAZIDE

60 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d1249cc1203d9f0e

Type

Standard